Small-molecule protein tyrosine phosphatase inhibition as a neuroprotective treatment after spinal cord injury in adult rats

Journal of Neuroscience

Volumn 28, Issue 29, 2008, Pages 7293-7303

  Nakashima, Shojiro ^a,b   Arnold, Sheila A ^a,b   Mahoney, Edward T ^a,b   Sithu, Srinivas D ^a,b   Zhang, Y Ping ^a,b   D'Souza, Stanley E ^a,b   Shields, Christopher B ^a,b   Hagg, Theo ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Axon; Blood vessel; Degeneration; Myelin; Neuroprotection; Sensory

Indexed keywords

POTASSIUM BISPEROXO(1,10 PHENANTHROLINE)OXOVANADATE; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE; AUTACOID; BISPEROXO(1,10 PHENANTHROLINE)OXOVANADATE(1 ); BISPEROXO(1,10-PHENANTHROLINE)OXOVANADATE(1-); NEUROPROTECTIVE AGENT; ORGANOMETALLIC COMPOUND; PHENANTHROLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; EVOKED SOMATOSENSORY RESPONSE; FEMALE; GRACILE NUCLEUS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SENSORY NERVE; SPINAL CORD ATROPHY; SPINAL CORD INJURY; THORACIC SPINAL CORD; WALKING; WHITE MATTER; ANIMAL; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION MEDIATORS; NEUROPROTECTIVE AGENTS; ORGANOMETALLIC COMPOUNDS; PHENANTHROLINES; PROTEIN TYROSINE PHOSPHATASES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES;

EID: 49049114995     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1826-08.2008     Document Type: Article

References (52)

1. Airaksinen MS, Saarma M (2002) The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3:383-394.
2. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T (2004) Protein tyrosine phosphatases in the human genome. Cell 117:699-711.
3. Baker KA, Hagg T (2005) An adult rat spinal cord contusion model of sensory axon degeneration: the estrus cycle or a preconditioning lesion do not affect outcome. J Neurotrauma 22:415-428.
4. Baker KA, Nakashima S, Hagg T (2007) Dorsal column sensory axons lack TrkC and are not rescued by local neurotrophin-3 infusions following spinal cord contusion in adult rats. Exp Neurol 205:82-91.
5. Ballermann M, McKenna J, Whishaw IQ (2001) A grasp-related deficit in tactile discrimination following dorsal column lesion in the rat. Brain Res Bull 54:237-242.
6. Band CJ, Posner BI, Dumas V, Contreres JO (1997) Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen). Mol Endocrinol 11:1899-1910.
7. Bevan AP, Drake PG, Yale JF, Shaver A, Posner BI (1995) Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis. Mol Cell Biochem 153:49-58.
8. Blanchette J, Pouliot P, Olivier M (2007) Role of protein tyrosine phosphatases in the regulation of interferon-γ-induced macrophage nitric oxide generation: implication of ERK pathway and AP-1 activation. J Leukoc Biol 81:835-844.
9. Bowes M, Tuszynski MH, Conner J, Zivin JA (2000) Continuous intrathecal fluid infusions elevate nerve growth factor levels and prevent functional deficits after spinal cord ischemia. Brain Res 883:178-183.
10. Brodal P (1992) The central nervous system: structure and function. New York: Oxford UP.
11. 2 generation. Cell Biol Toxicol 23:413-420.
12. Casella GT, Bunge MB, Wood PM (2006) Endothelial cell loss is not a major cause of neuronal and glial cell death following contusion injury of the spinal cord. Exp Neurol 202:8-20.
13. Cerovac Z, Ban J, Morinville A, Yaccato K, Shaver A, Maysinger D (1999) Activation of MAPK by potassium bisperoxo(1,10-phenanthroline) oxovanadate (V). Neurochem Int 34:337-344.
14. Cliffer KD, Giesler GJ Jr (1989) Postsynaptic dorsal column pathway of the rat. III. Distribution of ascending afferent fibers. J Neurosci 9:3146-3168.
15. Drake PG, Bevan AP, Burgess JW, Bergeron JJ, Posner BI (1996) A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo. Endocrinology 137:4960-4968.
16. Fantus IG, Deragon G, Lai R, Tang S (1995) Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling. Mol Cell Biochem 153:103-112.
17. Faure R, Vincent M, Dufour M, Shaver A, Posner BI (1995) Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: studies on a neuronal and a glial cell line. J Cell Biochem 59:389-401.
18. Ganchrow D, Margolin JK, Bernstein JJ (1980) Component analysis of hind limb behavioral alterations after damage to the rat dorsal funiculus. Exp Neurol 70:339-355.
19. Gris D, Marsh DR, Oatway MA, Chen Y, Hamilton EF, Dekaban GA, Weaver LC (2004) Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci 24:4043-4051.
20. Hagg T, Oudega M (2006) Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma 23:264-280.
21. Hains BC, Saab CY, Lo AC, Waxman SG (2004) Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI. Exp Neurol 188:365-377.
22. Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609-642.
23. Hubscher CH, Johnson RD (2006) Chronic spinal cord injury induced changes in the responses of thalamic neurons. Exp Neurol 197:177-188.
24. Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, Ramachandran C (1997) Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem 272:843-851.
25. Iannotti C, Ping Zhang Y, Shields CB, Han Y, Burke DA, Xu XM (2004) A neuroprotective role of glial cell line-derived neurotrophic factor following moderate spinal cord contusion injury. Exp Neurol 189:317-332.
26. Johnson KG, Van Vactor D (2003) Receptor protein tyrosine phosphatases in nervous system development. Physiol Rev 83:1-24.
27. Krejsa CM, Nadler SG, Esselstyn JM, Kavanagh TJ, Ledbetter JA, Schieven GL (1997) Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. Redox independent activation of NF-kappaB. J Biol Chem 272:11541-11549.
28. Li S, Li X, Rozanski GJ (2003) Regulation of glutathione in cardiac myocytes. J Mol Cell Cardiol 35:1145-1152.
29. Liverman CT, Altevogt BM, Joy JE, Johnson RT,eds (2005) Spinal cord injury: progress, promise, and priorities. Washington, DC: National Academies.
30. Loy DN, Crawford CH, Darnall JB, Burke DA, Onifer SM, Whittemore SR (2002) Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat. J Comp Neurol 445:308-324.
31. Lu X, Maysinger D, Hagg T (2002) Tyrosine phosphatase inhibition enhances neurotrophin potency and rescues nigrostriatal neurons in adult rats. Exp Neurol 178:259-267.
32. McKenna JE, Whishaw IQ (1999) Complete compensation in skilled reaching success with associated impairments in limb synergies, after dorsal column lesion in the rat. J Neurosci 19:1885-1894.
33. Paul S, Lombroso PJ (2003) Receptor and nonreceptor protein tyrosine phosphatases in the nervous system. Cell Mol Life Sci 60:2465-2482.
34. Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, Stokes BT (1999) Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 158:351-365.
35. Popovich PG, Guan Z, McGaughy V, Fisher L, Hickey WF, Basso DM (2002) The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J Neuropathol Exp Neurol 61:623-633.
36. Posner BI, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Lum BS (1994) Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol Chem 269:4596-4604.
37. Rabchevsky AG, Fugaccia I, Sullivan PG, Scheff SW (2001) Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J Neurotrauma 18:513-522.
38. Ruff SJ, Chen K, Cohen S (1997) Peroxovanadate induces tyrosine phosphorylation of multiple signaling proteins in mouse liver and kidney. J Biol Chem 272:1263-1267.
39. Rumora L, Hadzija M, Maysinger D, Zanić-Grubisić T (2004) Positive regulation of ERK activation and MKP-1 expression by peroxovanadium complex bpV (phen). Cell Biol Toxicol 20:293-301.
40. Sayer FT, Oudega M, Hagg T (2002) Neurotrophins reduce degeneration of injured ascending sensory and corticospinal motor axons in adult rat spinal cord. Exp Neurol 175:282-296.
41. Schucht P, Raineteau O, Schwab ME, Fouad K (2002) Anatomical correlates of locomotor recovery following dorsal and ventral lesions of the rat spinal cord. Exp Neurol 176:143-153.
42. Schwartz G, Fehlings MG (2001) Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole. J Neurosurg 94:245-256.
43. Sekar N, Li J, Shechter Y (1996) Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research. Crit Rev Biochem Mol Biol 31:339-359.
44. Smith KJ, Bennett BJ (1987) Topographic and quantitative description of rat dorsal column fibres arising from the lumbar dorsal roots. J Anat 153:203-215.
45. Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, Woodard EJ, Snyder EY, Eichler ME, Friedlander RM (2004) Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci U S A 101:3071-3076.
46. Trupp M, Scott R, Whittemore SR, Ibáñez CF (1999) Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J Biol Chem 274:20885-20894.
47. Webb AA, Muir GD (2003) Unilateral dorsal column and rubrospinal tract injuries affect overground locomotion in the unrestrained rat. Eur J Neurosci 18:412-422.
48. Yang P, Dankowski A, Hagg T (2007) Protein tyrosine phosphatase inhibition reduces degeneration of dopaminergic substantia nigra neurons and projections in 6-OHDA treated adult rats. Eur J Neurosci 25:1332-1340.
49. Zhang YP, Iannotti C, Shields LB, Han Y, Burke DA, Xu XM, Shields CB (2004) Dural closure, cord approximation, and clot removal: enhancement of tissue sparing in a novel laceration spinal cord injury model. J Neurosurg 100:343-352.
50. Zhang YP, Shields LB, Zhang Y, Pei J, Xu XM, Hoskins R, Cai J, Qiu MS, Magnuson DS, Burke DA, Shields CB (2007) Use of magnetic stimulation to elicit motor evoked potentials, somatosensory evoked potentials, and H-reflexes in non-sedated rodents. J Neurosci Methods 165:9-17.
51. Zhang YP, Burke DA, Shields LB, Chekmenev SY, Dincman T, Zhang Y, Zheng Y, Burke DA, Smith RR, Benton RL, DeVries WH, Hu X, Magnuson DSK, Whittemore SR, Shields CB (2008) Combined assessment to discriminate small functional differences following spinal cord contusion based on precise vertebral stabilization and tissue displacement. J Neurotrauma, in press.
52. Zhao J, Moore AN, Redell JB, Dash PK (2007) Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci 27:10240-10248.